Skip to main content
Top
Published in: Respiratory Research 1/2006

Open Access 01-12-2006 | Research

CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation

Authors: Saula Ravasi, Simona Citro, Barbara Viviani, Valérie Capra, G Enrico Rovati

Published in: Respiratory Research | Issue 1/2006

Login to get access

Abstract

Background

Cysteine-containing leukotrienes (cysteinyl-LTs) are pivotal inflammatory mediators that play important roles in the pathophysiology of asthma, allergic rhinitis, and other inflammatory conditions. In particular, cysteinyl-LTs exert a variety of effects with relevance to the aetiology of asthma such as smooth muscle contraction, eosinophil recruitment, increased microvascular permeability, enhanced mucus secretion and decreased mucus transport and, finally, airway smooth muscle cells (ASMC) proliferation. We used human ASMC (HASMC) to identify the signal transduction pathway(s) of the leukotriene D4 (LTD4)-induced DNA synthesis.

Methods

Proliferation of primary HASMC was measured by [3H]thymidine incorporation. Phosphorylation of EGF receptor (EGF-R) and ERK1/2 was assessed with a polyclonal anti-EGF-R or anti-phosphoERKl/2 monoclonal antibody. A Ras pull-down assay kit was used to evaluate Ras activation. The production of reactive oxygen species (ROS) was estimated by measuring dichlorodihydrofluorescein (DCF) oxidation.

Results

We demonstrate that in HASMC LTD4-stimulated thymidine incorporation and potentiation of EGF-induced mitogenic signaling mostly depends upon EGF-R transactivation through the stimulation of CysLT1-R. Accordingly, we found that LTD4 stimulation was able to trigger the increase of Ras-GTP and, in turn, to activate ERK1/2. We show here that EGF-R transactivation was sensitive to pertussis toxin (PTX) and phosphoinositide 3-kinase (PI3K) inhibitors and that it occurred independently from Src activity, despite the observation of a strong impairment of LTD4-induced DNA synthesis following Src inhibition. More interestingly, CysLT1-R stimulation increased the production of ROS and N-acetylcysteine (NAC) abolished LTD4-induced EGF-R phosphorylation and thymidine incorporation.

Conclusion

Collectively, our data demonstrate that in HASMC LTD4 stimulation of a Gi/o coupled CysLT1-R triggers the transactivation of the EGF-R through the intervention of PI3K and ROS. While PI3K and ROS involvement is an early event, the activation of Src occurs downstream of EGF-R activation and is followed by the classical Ras-ERK1/2 signaling pathway to control G1 progression and cell proliferation.
Literature
1.
go back to reference Nicosia S, Capra V, Rovati GE: Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 2001,14(1):3–19.PubMedCrossRef Nicosia S, Capra V, Rovati GE: Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 2001,14(1):3–19.PubMedCrossRef
3.
go back to reference Halayko AJ, Amrani Y: Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003,137(2–3):209–222.PubMedCrossRef Halayko AJ, Amrani Y: Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003,137(2–3):209–222.PubMedCrossRef
4.
go back to reference Hamid Q, Tulic MK, Liu MC, Moqbel R: Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol 2003,111(1 Suppl):S5-S12. discussion S12–17PubMedCrossRef Hamid Q, Tulic MK, Liu MC, Moqbel R: Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol 2003,111(1 Suppl):S5-S12. discussion S12–17PubMedCrossRef
5.
go back to reference Black JL, Johnson PR: Factors controlling smooth muscle proliferation and airway remodelling. Curr Opin Allergy Clin Immunol 2002,2(1):47–51.PubMedCrossRef Black JL, Johnson PR: Factors controlling smooth muscle proliferation and airway remodelling. Curr Opin Allergy Clin Immunol 2002,2(1):47–51.PubMedCrossRef
7.
go back to reference Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001,164(10 Pt 2):S28–38.PubMedCrossRef Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001,164(10 Pt 2):S28–38.PubMedCrossRef
8.
go back to reference Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL: Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001,164(3):474–477.PubMedCrossRef Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL: Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001,164(3):474–477.PubMedCrossRef
9.
go back to reference Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M: Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003,167(10):1360–1368.PubMedCrossRef Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M: Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003,167(10):1360–1368.PubMedCrossRef
10.
go back to reference Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989,140(6):1745–1753.PubMedCrossRef Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989,140(6):1745–1753.PubMedCrossRef
11.
go back to reference Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr: Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003,111(1B):S18-S36.PubMedCrossRef Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr: Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003,111(1B):S18-S36.PubMedCrossRef
13.
go back to reference Fahy JV, Corry DB, Boushey HA: Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 2000,6(1):15–20.PubMedCrossRef Fahy JV, Corry DB, Boushey HA: Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 2000,6(1):15–20.PubMedCrossRef
14.
go back to reference Panettieri RA, Tan EM, Ciocca V, Luttmann MA, Leonard TB, Hay DW: Effects of LTD 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998,19(3):453–461.PubMedCrossRef Panettieri RA, Tan EM, Ciocca V, Luttmann MA, Leonard TB, Hay DW: Effects of LTD 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998,19(3):453–461.PubMedCrossRef
15.
go back to reference Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M: CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003,111(5):1032–1040.PubMedCrossRef Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M: CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003,111(5):1032–1040.PubMedCrossRef
16.
go back to reference Drazen JM, Israel E, O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999,340(3):197–206.PubMedCrossRef Drazen JM, Israel E, O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999,340(3):197–206.PubMedCrossRef
17.
go back to reference Capra V, Rovati GE: Leukotriene modifiers in asthma management. IDrugs 2004,7(7):659–666.PubMed Capra V, Rovati GE: Leukotriene modifiers in asthma management. IDrugs 2004,7(7):659–666.PubMed
18.
go back to reference Henderson JWR, Chiang GKS, Tien Y-t, Chi EY: Reversal of Allergen-induced Airway Remodeling by CysLT1 Receptor Blockade. Am J Respir Crit Care Med 2005, in press. Henderson JWR, Chiang GKS, Tien Y-t, Chi EY: Reversal of Allergen-induced Airway Remodeling by CysLT1 Receptor Blockade. Am J Respir Crit Care Med 2005, in press.
19.
go back to reference Ammit AJ, Panettieri RA Jr: Invited review: the circle of life: cell cycle regulation in airway smooth muscle. J Appl Physiol 2001,91(3):1431–1437.PubMed Ammit AJ, Panettieri RA Jr: Invited review: the circle of life: cell cycle regulation in airway smooth muscle. J Appl Physiol 2001,91(3):1431–1437.PubMed
20.
go back to reference Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T: International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol Rev 2003,55(1):195–227.PubMedCrossRef Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T: International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacol Rev 2003,55(1):195–227.PubMedCrossRef
21.
go back to reference Capra V: Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol Res 2004,50(1):1–11.PubMedCrossRef Capra V: Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol Res 2004,50(1):1–11.PubMedCrossRef
22.
go back to reference Capra V, Accomazzo MR, Ravasi S, Parenti M, Macchia M, Nicosia S, Rovati GE: Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat 2003,71(3–4):235–251.PubMedCrossRef Capra V, Accomazzo MR, Ravasi S, Parenti M, Macchia M, Nicosia S, Rovati GE: Involvement of prenylated proteins in calcium signaling induced by LTD4 in differentiated U937 cells. Prostaglandins Other Lipid Mediat 2003,71(3–4):235–251.PubMedCrossRef
23.
go back to reference Mellor EA, Frank N, Soler D, Hodge MR, Lora JM, Austen KF, Boyce JA: Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci USA 2003. Mellor EA, Frank N, Soler D, Hodge MR, Lora JM, Austen KF, Boyce JA: Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci USA 2003.
24.
go back to reference Kenakin T: Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 1997,18(12):456–464.PubMedCrossRef Kenakin T: Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci 1997,18(12):456–464.PubMedCrossRef
25.
go back to reference Marinissen MJ, Gutkind JS: G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001, 22:368–376.PubMedCrossRef Marinissen MJ, Gutkind JS: G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001, 22:368–376.PubMedCrossRef
26.
go back to reference Capra V, Ravasi S, Accomazzo MR, Parenti M, Rovati GE: CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem Pharmacol 2004,67(8):1569–1577.PubMedCrossRef Capra V, Ravasi S, Accomazzo MR, Parenti M, Rovati GE: CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras. Biochem Pharmacol 2004,67(8):1569–1577.PubMedCrossRef
27.
go back to reference Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996,379(6565):557–560.PubMedCrossRef Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996,379(6565):557–560.PubMedCrossRef
28.
go back to reference McMahon B, Mitchell D, Shattock R, Martin F, Brady HR, Godson C: Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 2002,16(13):1817–1819.PubMed McMahon B, Mitchell D, Shattock R, Martin F, Brady HR, Godson C: Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 2002,16(13):1817–1819.PubMed
29.
go back to reference Zhou L, Hershenson MB: Mitogenic signaling pathways in airway smooth muscle. Respir Physiol Neurobiol 2003,137(2–3):295–308.PubMedCrossRef Zhou L, Hershenson MB: Mitogenic signaling pathways in airway smooth muscle. Respir Physiol Neurobiol 2003,137(2–3):295–308.PubMedCrossRef
30.
go back to reference Krymskaya VP, Orsini MJ, Eszterhas AJ, Brodbeck KC, Benovic JL, Panettieri RA Jr, Penn RB: Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000,23(4):546–554.PubMedCrossRef Krymskaya VP, Orsini MJ, Eszterhas AJ, Brodbeck KC, Benovic JL, Panettieri RA Jr, Penn RB: Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000,23(4):546–554.PubMedCrossRef
31.
go back to reference Capra V, Habib A, Accomazzo MR, Ravasi S, Citro S, Levy-Toledano S, Nicosia S, Rovati GE: Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation. Eur J Pharmacol 2003,474(2–3):149–159.PubMedCrossRef Capra V, Habib A, Accomazzo MR, Ravasi S, Citro S, Levy-Toledano S, Nicosia S, Rovati GE: Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation. Eur J Pharmacol 2003,474(2–3):149–159.PubMedCrossRef
32.
go back to reference Citro S, Ravasi S, Rovati GE, Capra V: Thromboxane prostanoid receptor signals through Gi protein to rapidly activate ERK in human airways. Am J Respir Cell Mol Biol 2005, 32:326–333.PubMedCrossRef Citro S, Ravasi S, Rovati GE, Capra V: Thromboxane prostanoid receptor signals through Gi protein to rapidly activate ERK in human airways. Am J Respir Cell Mol Biol 2005, 32:326–333.PubMedCrossRef
33.
go back to reference Accomazzo MR, Rovati GE, Vigano T, Hernandez A, Bonazzi A, Bolla M, Fumagalli F, Viappiani S, Galbiati E, Ravasi S, et al.: Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+- independent. Am J Respir Crit Care Med 2001,163(1):266–272.PubMedCrossRef Accomazzo MR, Rovati GE, Vigano T, Hernandez A, Bonazzi A, Bolla M, Fumagalli F, Viappiani S, Galbiati E, Ravasi S, et al.: Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+- independent. Am J Respir Crit Care Med 2001,163(1):266–272.PubMedCrossRef
34.
go back to reference Lynch KR, Gary P, O'neill GP, Qingyun Liu Q, Im D-S, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, et al.: Characterization of the human cysteinyl leukotriene CysLT 1 receptor. Nature 1999, 399:789–793.PubMedCrossRef Lynch KR, Gary P, O'neill GP, Qingyun Liu Q, Im D-S, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, et al.: Characterization of the human cysteinyl leukotriene CysLT 1 receptor. Nature 1999, 399:789–793.PubMedCrossRef
35.
go back to reference Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im D-S, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, et al.: Characterization of the Human Cysteinyl Leukotriene 2 Receptor. J Biol Chem 2000,275(39):30531–30536.PubMedCrossRef Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im D-S, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, et al.: Characterization of the Human Cysteinyl Leukotriene 2 Receptor. J Biol Chem 2000,275(39):30531–30536.PubMedCrossRef
36.
go back to reference Capra V, Nicosia S, Ragnini D, Mezzetti M, Keppler D, Rovati GE: Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. Mol Pharmacol 1998,53(4):750–758.PubMed Capra V, Nicosia S, Ragnini D, Mezzetti M, Keppler D, Rovati GE: Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. Mol Pharmacol 1998,53(4):750–758.PubMed
37.
go back to reference Rovati GE: Ligand-binding studies: old beliefs and new strategies. Trends Pharmacol Sci 1998,19(9):365–369.PubMedCrossRef Rovati GE: Ligand-binding studies: old beliefs and new strategies. Trends Pharmacol Sci 1998,19(9):365–369.PubMedCrossRef
38.
go back to reference Rovati GE, Giovanazzi S, Mezzetti M, Nicosia S: Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma. Biochem Pharmacol 1992,44(7):1411–1415.PubMedCrossRef Rovati GE, Giovanazzi S, Mezzetti M, Nicosia S: Heterogeneity of binding sites for ICI 198,615 in human lung parenchyma. Biochem Pharmacol 1992,44(7):1411–1415.PubMedCrossRef
39.
go back to reference McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C: Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem 2000,275(36):27566–27575.PubMed McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C: Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem 2000,275(36):27566–27575.PubMed
40.
go back to reference Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjolander A: Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 2002,115(Pt 9):1883–1893.PubMed Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjolander A: Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 2002,115(Pt 9):1883–1893.PubMed
41.
go back to reference Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA Jr, Penn RB: MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am J Physiol 1999,277(3 Pt 1):L479–488.PubMed Orsini MJ, Krymskaya VP, Eszterhas AJ, Benovic JL, Panettieri RA Jr, Penn RB: MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. Am J Physiol 1999,277(3 Pt 1):L479–488.PubMed
42.
go back to reference Lee JH, Johnson PR, Roth M, Hunt NH, Black JL: ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001,280(5):L1019–1029.PubMed Lee JH, Johnson PR, Roth M, Hunt NH, Black JL: ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001,280(5):L1019–1029.PubMed
43.
go back to reference Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995,270(5234):296–299.PubMedCrossRef Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995,270(5234):296–299.PubMedCrossRef
44.
go back to reference Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, Hershenson MB: Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999,274(31):22065–22071.PubMedCrossRef Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, Hershenson MB: Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999,274(31):22065–22071.PubMedCrossRef
45.
go back to reference Henderson WR Jr, Tang L-O, Chu S-J, Tsao S-M, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, Chi EY: A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model. Am J Respir Crit Care Med 2002,165(1):108–116.PubMedCrossRef Henderson WR Jr, Tang L-O, Chu S-J, Tsao S-M, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, Chi EY: A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model. Am J Respir Crit Care Med 2002,165(1):108–116.PubMedCrossRef
46.
go back to reference Vargaftig BB, Singer M: Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am J Physiol Lung Cell Mol Physiol 2003,285(4):L808–818.PubMedCrossRef Vargaftig BB, Singer M: Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am J Physiol Lung Cell Mol Physiol 2003,285(4):L808–818.PubMedCrossRef
47.
go back to reference Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999,402(6764):884–888.PubMed Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999,402(6764):884–888.PubMed
48.
go back to reference Wymann MP, Zvelebil M, Laffargue M: Phosphoinositide 3-kinase signalling – which way to target? Trends Pharmacol Sci 2003,24(7):366–376.PubMedCrossRef Wymann MP, Zvelebil M, Laffargue M: Phosphoinositide 3-kinase signalling – which way to target? Trends Pharmacol Sci 2003,24(7):366–376.PubMedCrossRef
49.
go back to reference Krymskaya VP, Goncharova EA, Ammit AJ, Lim PN, Goncharov DA, Eszterhas A, Panettieri RA Jr: Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J 2005,19(3):428–430.PubMed Krymskaya VP, Goncharova EA, Ammit AJ, Lim PN, Goncharov DA, Eszterhas A, Panettieri RA Jr: Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J 2005,19(3):428–430.PubMed
50.
go back to reference Shah BH, Olivares-Reyes JA, Catt KJ: The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)py rrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Mol Pharmacol 2005,67(1):184–194.PubMedCrossRef Shah BH, Olivares-Reyes JA, Catt KJ: The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)py rrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Mol Pharmacol 2005,67(1):184–194.PubMedCrossRef
51.
go back to reference Wetzker R, Bohmer FD: Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 2003,4(8):651–657.PubMedCrossRef Wetzker R, Bohmer FD: Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 2003,4(8):651–657.PubMedCrossRef
52.
go back to reference Pandya HC, Snetkov VA, Twort CH, Ward JP, Hirst SJ: Oxygen regulates mitogen-stimulated proliferation of fetal human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002,283(6):L1220–1230.PubMedCrossRef Pandya HC, Snetkov VA, Twort CH, Ward JP, Hirst SJ: Oxygen regulates mitogen-stimulated proliferation of fetal human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2002,283(6):L1220–1230.PubMedCrossRef
53.
go back to reference Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, Sattler M: Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005,105(4):1717–1723.PubMedCrossRef Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, Salgia R, Podar K, Griffin JD, Sattler M: Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005,105(4):1717–1723.PubMedCrossRef
54.
go back to reference Weiss EB, Bellino JR: Leukotriene-associated toxic oxygen metabolites induce airway hyperreactivity. Chest 1986,89(5):709–716.PubMedCrossRef Weiss EB, Bellino JR: Leukotriene-associated toxic oxygen metabolites induce airway hyperreactivity. Chest 1986,89(5):709–716.PubMedCrossRef
55.
go back to reference Braga PC, Dal Sasso M, Dal Negro R: Inhibitory effects of zafirlukast on respiratory bursts of human neutrophils. Drugs Exp Clin Res 2002,28(4):133–145.PubMed Braga PC, Dal Sasso M, Dal Negro R: Inhibitory effects of zafirlukast on respiratory bursts of human neutrophils. Drugs Exp Clin Res 2002,28(4):133–145.PubMed
56.
go back to reference Suzuki M, Kato M, Kimura H, Fujiu T, Morikawa A: Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078). J Asthma 2003,40(4):395–404.PubMedCrossRef Suzuki M, Kato M, Kimura H, Fujiu T, Morikawa A: Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078). J Asthma 2003,40(4):395–404.PubMedCrossRef
57.
go back to reference Blaukat A, Barac A, Cross MJ, Offermanns S, Dikic I: G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals. Mol Cell Biol 2000,20(18):6837–6848.PubMedPubMedCentralCrossRef Blaukat A, Barac A, Cross MJ, Offermanns S, Dikic I: G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals. Mol Cell Biol 2000,20(18):6837–6848.PubMedPubMedCentralCrossRef
58.
go back to reference Leikauf GD, Claesson HE, Doupnik CA, Hybbinette S, Grafstrom RC: Cysteinyl leukotrienes enhance growth of human airway epithelial cells. Am J Physiol 1990,259(4 Pt 1):L255–261.PubMed Leikauf GD, Claesson HE, Doupnik CA, Hybbinette S, Grafstrom RC: Cysteinyl leukotrienes enhance growth of human airway epithelial cells. Am J Physiol 1990,259(4 Pt 1):L255–261.PubMed
Metadata
Title
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation
Authors
Saula Ravasi
Simona Citro
Barbara Viviani
Valérie Capra
G Enrico Rovati
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2006
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-7-42

Other articles of this Issue 1/2006

Respiratory Research 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine